Quantitative analysis in magnetic resonance spectroscopy: From metabolic profiling to in vivo biomarkers

Bioanalysis

Volumn 4, Issue 3, 2012, Pages 321-341

  Serkova, Natalie J ^a   Brown, Mark S ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CARBOHYDRATE; CARBON 13; CREATININE; INOSITOL; LACTIC ACID; N ACETYLASPARTIC ACID; N ACETYLASPARTYLGLUTAMIC ACID; PHOSPHORUS 31; POTASSIUM; SODIUM 23;

ANALYTIC METHOD; BIOMEDICINE; CLINICAL PROTOCOL; DISEASE MARKER; ENERGY METABOLISM; EX VIVO STUDY; GLIA CELL; GLUCOSE METABOLISM; HUMAN; IMAGE PROCESSING; IN VIVO STUDY; INFLAMMATION; MATHEMATICAL COMPUTING; MEMBRANE BIOLOGY; METABOLOMICS; MOLECULAR IMAGING; NERVE CONDUCTION; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PROTON NUCLEAR MAGNETIC RESONANCE; QUANTITATIVE ANALYSIS; REVIEW; SIGNAL TRANSDUCTION;

BIOLOGICAL MARKERS; BODY FLUIDS; HUMANS; INOSITOL; ISOTOPE LABELING; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; METABOLOME; NEOPLASMS;

EID: 84863419278     PISSN: 17576180     EISSN: 17576199     Source Type: Journal    
DOI: 10.4155/bio.11.320     Document Type: Review

References (175)

1. Gore J. Out of the shadows: MRI and the Nobel Prize. N. Engl. J. Med. 349, 2290-2292 (2003). (Pubitemid 37509736)
2. Lauterbur PC. Nobel Lecture: all science is interdisciplinary - from magnetic moments to molecules to men. Biosci. Rep. 24, 165-178 (2004). (Pubitemid 41185772)
3. Mansfield P. Snapshot magnetic resonance imaging (Nobel lecture). Angew. Chem. Int. Ed. Engl. 43, 5456-5464 (2004). (Pubitemid 39486659)
4. Serkova NJ, Niemann CU. Pattern recognition and biomarker validation using quantitative 1H-NMR based metabolomics. Expert Rev. Mol. Diagn. 6, 717-731 (2006). (Pubitemid 44525597)
5. Abraham RJ, Fisher J, Loftus P. Introduction to NMR Spectroscopy. John Wiley & Sons, Chichester, UK (1997).
6. Gadian DG. NMR and Its Applications into Living Systems. Oxford University Press, Oxford, UK 1995.
7. Spratlin JL, Serkova NJ, Eckhardt SG. Clinical application of metabolomics in oncology: a review. Clin. Cancer Res. 15, 431-440 (2009).
8. Serkova NJ, Standiford TJ, Stringer KA. The emerging field of quantitative blood metabolomics for biomarker discovery in critical illnesses. Am. J. Resp. Crit. Care Med. doi:10.1164/rccm.201103-0474CI (2011) (Epub ahead of print).
9. Tikunov Y, Lommen A, Ric de Vos CH et al. A novel approach for nontargeted data analysis for metabolomics. Large-scale profiling of tomato fruit volatiles. Plant Physiol. 139, 1125-1137 (2005). (Pubitemid 43790853)
10. Lindon GC, Nicholson JK, Everett JR. NMR spectroscopy of biofluids. Ann. Report NMR Spectrosc. 38, 1-65 (1999).
11. Oehr P. 'Omics'-based imaging in cancer detection and therapy. Personal. Med. 3, 19-32 (2006).
12. Serkova NJ, Garg K, Bradshaw-Pierce EL. Oncologic imaging endpoints for the assessment of therapy response. Recent Patents Anticancer Drug Discov. 4, 36-53 (2009).
13. Lenz EM, Bright J, Knight R et al. Cyclosporin A-induced changes in endogenous metabolites in rat urine: a metabonomic investigation using high field 1H NMR spectroscopy, HPLC-TOF/MS and chemometrics. J. Pharm. Biomed. Anal. 35, 599-608 (2004). (Pubitemid 38609380)
14. Mortishire-Smith RJ, Skiles GL, Lawrence JW et al. Use of metabonomics to identify impaired fatty acid metabolism as the mechanism of a drug-induced toxicity. Chem. Res. Toxicol. 17, 165-173 (2004). (Pubitemid 38252496)
15. Azmi J, Connelly J, Holmes E et al. Characterization of the biochemical effects of 1-nitronaphthalene in rats using global metabolic profiling by NMR spectroscopy and pattern recognition. Biomarkers 10, 401-416 (2005).
16. Waters NJ, Waterfield CJ, Farrant RD, Holmes E, Nicholson JK. Metabonomics deconvolution of embedded toxicity: application to thioacetamide hepato- and nephrotoxicity. Chem. Res. Toxicol. 18, 639-654 (2005). (Pubitemid 40563278)
17. Yang HJ, Choi MJ, Wen H et al. An effective assessment of simvastatin-induced toxicity with NMR-based metabonomics approach. PLoS One 6, e16641 (2011).
18. Suhre K, Wallaschofski H, Raffler J et al. A genome-wide association study of metabolic traits in human urine. Nat. Genet. 43, 565-569 (2011).
19. Wevers RA, Engelke UF, Moolenaar SH et al. 1H-NMR spectroscopy of body fluids: inborn errors of purine and pyrimidine metabolism. Clin. Chem. 45, 539-548 (1999). (Pubitemid 29165965)
20. Engelke UF, Kremer B, Kluijtmans LA et al. NMR spectroscopic studies on the late onset form of 3-methylglutaconic aciduria type I and other defects in leucine metabolism. NMR Biomed. 19, 271-278 (2006).
21. Gronwald W, Klein MS, Kaspar H et al. Urinary metabolite quantification employing 2D NMR spectroscopy. Anal. Chem. 80, 9288-9297 (2008).
22. Tzovaras VT, Psychogiod NG, Kostara CE, Bairaktari ET, Elisaf MS. Evaluation of the proximal tubular function in individuals with primary renal hypouricemia: an NMR-based metabonomic study. NMR Biomed. 22, 1072-1083 (2009).
23. Hauet T, Baumert H, Gibelin H et al. Citrate, acetate and renal medullary osmolyte excretion in urine as predictor of renal changes after cold ischaemia and transplantation. Clin. Chem. Lab. Med. 38, 1093-1098 (2000). (Pubitemid 32040858)
24. Hauet T, Baumert H, Gibelin H et al. Noninvasive monitoring of citrate, acetate, lactate, and renal medullary osmolyte excretion in urine as biomarkers of exposure to ischemic reperfusion injury. Cryobiology 41, 280-291 (2000). (Pubitemid 32187989)
25. Saxena V, Gupta A, Nagana Gowda GA et al. 1H-NMR spectroscopy for the prediction of therapeutic outcome in patients with fulminant hepatic failure. NMR Biomed. 19, 521-526 (2006).
26. Legido-Quigley C, Cloarec O, Parker DA et al. First example of hepatocyte transplantation to alleviate oenithine transcarbamylase deficiency, monitored by NMR-based metabonomics. Bioanalysis 1, 1527-1535 (2009).
27. Fuller TF, Serkova N, Niemann CU, Freise CE. Influence of donor pretreatment with N-acetylcysteine on ischemia/reperfusion injury in rat kidney grafts. J. Urol. 171, 1296-1300 (2004). (Pubitemid 38327598)
28. Serkova N, Fuller TF, Klawitter J et al. H-NMR-based metabolic signatures of mild and severe ischemia/reperfusion injury in rat kidney transplants. Kidney Int. 67, 1142-1151 (2005). (Pubitemid 41623341)
29. Serkova NJ, Zhang Y, Coatney JL et al. Early detection of graft failure using the blood metabolic profile of a liver recipient. Transplantation 83, 517-521 (2007). (Pubitemid 46667858)
30. Wishart DS. Metabolomics: the principles and potential applications to transplantation. Am. J. Transplant. 5, 2814-2820 (2005). (Pubitemid 43923941)
31. Whitfield PD, German AJ, Noble PJ. Metabolomics: an emerging postgenomic tool for nutrition. Br. J. Nutr. 92, 549-555 (2004). (Pubitemid 39406637)
32. Serkova NJ, Jackman M, Brown JL et al. Metabolic profiling of livers and blood from obese Zucker rats. J. Hepatol. 44, 956-962 (2006).
33. Duggan GE, Hittel DS, Sensen CW et al. Metabolic response to exercise training in lean and diet-induced obese mice. J. Appl. Physiol. 110, 1311-1318 (2011).
34. Azmi J, Griffin JL, Shore RF et al. Chemometric analysis of biofluids following toxicant induced hepatotoxicity: a metabonomic approach to distinguish the effects of 1-naphthylisothiocyanate from its products. Xenobiotica 35, 839-852 (2005). (Pubitemid 41665519)
35. Dabos KJ, Newsome PN, Parkinson JA et al. A biochemical prognostic model of outcome in paracetamol-induced acute liver injury. Transplantation 80, 1712-1717 (2005). (Pubitemid 43053996)
36. Coen M, Lenz EM, Nicholson JK et al. An integrated metabonomic investigation of acetaminophen toxicity in the mouse using NMR spectroscopy. Chem. Res. Toxicol. 16, 295-303 (2003). (Pubitemid 36373694)
37. Maddox JF, Luyendyk JP, Cosma GN et al. Metabonomic evaluation of idiosyncrasy-like liver injury in rats correlated with ranitidine and lipopolysaccharide. Toxicol. Appl. Pharmacol. 212, 35-44 (2006).
38. Serkova NJ, Christians U. Biomarkers for toxicodynamic monitoring of immunosuppressants: NMR-based quantitative metabonomics of the blood. Ther. Drug Monit. 27, 733-737 (2005). (Pubitemid 44391725)
39. Odunsi K, Wollman RM, Ambrosone CB et al. Detection of epithelial ovarian cancer using 1H-NMR-based metabonomics. Int. J. Cancer 113, 782-788 (2005). (Pubitemid 40101260)
40. Tiziani S, Lopes V, Gunther UL. Early stage diagnosis of oral cancer using 1H-NMR-based metabolomics. Neoplasia 11, 269-276 (2009).
41. Asiago VM, Alvarado LZ, Shanaiah N et al. Early detection of recurrent breast cancer using metabolite profiling. Cancer Res. 70, 8309-8318 (2010).
42. Gu H, Pan Z, Xi B, Asiago V, Musselman B, Raftery D. Principal component directed partial least squares analysis for combining nuclear magnetic resonance and mass spectrometry data in metabolomics: application to the detection of breast cancer. Anal. Chim. Acta 686, 57-63 (2011).
43. Ouyang D, Xu J, Huang H, Chen Z. Metabolomic profiling of serum from human pancreatic cancer patients using 1H-NMR spectroscopy and principal component analysis. Appl. Biochem. Biotechnol. 165, 148-154 (2011).
44. Brindle JT, Antti H, Holmes E et al. Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using 1H-NMR-based metabonomics. Nat. Med. 8, 1439-1444 (2002). (Pubitemid 36019430)
45. Tissot van Patot MC, Serkova NJ, Haschke M et al. Enhanced leukocyte HIF-1alpha and HIF-1 DNA bindings in humans after rapid ascent to 4300 m. Free Radic. Biol. Med. 46, 1551-1557 (2009).
46. Cohen MJ, Serkova NJ, Wiener-Kronish J, Pittet JF, Niemann CU. 1H-NMR-based metabolic signatures of clinical outcomes in trauma patients - beyond lactate and base deficit. J. Trauma 69, 31-40 (2010).
47. Stringer KA, Serkova NJ, Karnovsky A et al. Metabolic consequences of sepsis-induced acute lung injury revealed by plasma 1H-nuclear magnetic resonance quantitative metabolomics and computational analysis. Am. J. Physiol. Lung Cell Mol. Physiol. 300, L4-L11 (2011).
48. Lin ZY, Xu PB, Yan SK et al. A metabonomic approach to early prognostic evaluation of experimental sepsis by 1H-NMR and pattern recognition. NMR Biomed. 22, 601-608 (2009).
49. Averna TA, Kline EE, Smith AY, Sillerud LO. A decrease in 1H nuclear magnetic resonance spectroscopically determined citrate in human seminal fluid accompanies the development of prostate adenocarcinoma. J. Urol. 173, 433-438 (2005).
50. Serkova NJ, Gamito EJ, Jones RH et al. The metabolite citrate, myoinositol, and spermine are potential age-independent markers of prostate cancer in human expressed prostatic secretions. Prostate 68, 620-628 (2008). (Pubitemid 351614640)
51. Melendez HV, Ahmadi D, Parkes HG et al. Proton nuclear magnetic resonance analysis of hepatic bile from donors and recipients in human liver transplantation. Transplantation 72, 855-860 (2001). (Pubitemid 32879858)
52. Paczkowska A, Toczylowska B, Nyckowski P et al. High-resolution 1H nuclear magnetic resonance spectroscopy analysis of bile samples obtained from a patient after orthotopic liver transplantation: new perspectives. Transplant. Proc. 35, 2278-2280 (2003). (Pubitemid 37194390)
53. Dunne VG, Bhattachayya S, Besser M et al. Metabolites from cerebrospinal fluid in aneurysmal subarachnoid haemorrhage correlate with vasospasm and clinical outcome: a patterN-recognition 1H-NMR study. NMR Biomed. 18, 24-33 (2005). (Pubitemid 40347540)
54. De Laurentiis G, Paris D, Melck D et al. Metabonomic analysis of exhaled breath condensate in adults by nuclear magnetic resonance spectroscopy. Eur. Respir. J. 32, 1175-1183 (2008).
55. Bertram HC, Eggers N, Eller N. Potential of human saliva for nuclear magnetic resonance-based metabolomics and for health-related biomarker identification. Anal. Chem. 81, 9188-9193 (2009).
56. Martinez-Granados B, Monleon D, Martinez-Bisbal MC et al. Metabolite identification in human liver needle biopsies by high-resolution magic angle spinning 1H-NMR spectroscopy. NMR Biomed. 19, 90-100 (2006). (Pubitemid 43250794)
57. Burns MA, Taylor JL, Wu CL et al. Reduction of spinning sidebands in proton NMR of human prostate tissue with slow high-resolution magic angle spinning. Magn. Reson. Med. 54, 34-42 (2005). (Pubitemid 40898394)
58. Opstad KS, Bell BA, Griffiths JR, Howe FA. An assessment of the effects of sample ischemia and spinning time on the metabolite profile of brain tumour biopsy specimens as determined by high-resolution magic angle spinning 1H-NMR. NMR Biomed. 21, 1138-1147 (2008).
59. Opstad KS, Bell BA, Griffiths JR, Rowe FA. Towards accurate quantification of metabolite, lipids, and macromolecules in HRMAS spectra of human brain tumor biopsies using LCModel. Magn. Reson. Med. 60, 1237-1242 (2008).
60. De Silva SS, Payne GS, Thomas V et al. Investigation of metabolite changes in the transition from preinvasive to invasive cervical cancer measured using 1H and 31P magic angle spinning MRS of intact tissue. NMR Biomed. 22, 191-198 (2009).
61. Wilson M, Davies NP, Brundler MA et al. High-resolution magic angle spinning 1H-NMR of childhood brain and nervous system tumours. Mol. Cancer 8, 6 (2009).
62. Sitter B, Bathen TF, Singstad TE et al. Quantification of metabolites in breast cancer patients with different clinical prognosis using HR MAS MR spectroscopy. NMR Biomed 23, 424-431 (2010).
63. Cuellar-Baena S, Morales JM, Martinetto H et al. Comparative metabolic profiling of paediatric ependymoma, medulloblastoma and pilocytic astrocytoma. Int. J. Mol. Med. 26, 941-948 (2010).
64. Moestue S, Sitter B, Bathen TF, Tessem MB, Gribbestad IS. HR MAS spectroscopy in metabolic characterization of cancer. Curr. Top. Med. Chem. 11, 2-26 (2011).
65. Griffin JL. Metabonomics: NMR spectroscopy and pattern recognition analysis of body fluids and tissues for characterization of xenobiotic toxicity and disease diagnosis. Curr. Opin Chem. Biol. 7, 648-654 (2003). (Pubitemid 37315803)
66. Serkova NJ, Freund AS, Brown JL, Kominsky DJ. Use of the 1-mm micro-probe for metabolic analysis on small volume biological samples. J. Cell. Mol. Med. 12, 1933-1941 (2009).
67. Lenz EM, Bright J, Wilson ID et al. A 1H-NMR-based metabonomic study of urine and plasma samples obtained from healthy human subjects. J. Pharm. Biomed. Anal. 33, 1103-1115 (2003). (Pubitemid 37501013)
68. Tang H, Wang Y, Nicholson JK, Lindon JC. Use of relaxation-edited one-dimensional and two dimensional nuclear magnetic resonance spectroscopy to improve detection of small metabolites in blood plasma. Anal. Biochem. 325, 260-272 (2004). (Pubitemid 38134363)
69. Serkova NJ, Glunde K. Metabolomics of cancer. Methods Mol. Biol. 520, 273-295 (2009).
70. Silvestre V, Goupry S, Trierweiler M et al. Determination of substrate and product concentrations in lactic acid bacterial fermentations by proton NMR using the ERETIC method. Anal. Chem. 73, 1862-1868 (2001). (Pubitemid 32862454)
71. Loening NM, Chamberlin AM, Zepeda AG et al. Quantification of phosphocholine and glycerophosphocholine with 31P-edited 1H-NMR spectroscopy. NMR Biomed. 18, 413-420 (2005). (Pubitemid 41646182)
72. Zektzer AS, Swanson MG, Jarso S et al. Improved signal to noise in high-resolution magic angle spinning total correlation spectroscopy studies of prostate tissues using rotor-synchronized adiabatic pulses. Magn. Reson. Med. 53, 41-48 (2005). (Pubitemid 40123228)
73. Hansen MAE. Metabolome Analysis: an Introduction. John Wiley & Sons, Inc., Hoboken, NJ, USA 2007.
74. Granot J. Selected volume excitation using stimulated echoes (VEST). Application to spatially localizied spectroscopy and imaging. J. Magn. Reson. 70, 488-492 (1986).
75. Frahm J, Merboldt KD, H'nicke W. Localized proton spectroscopy using stimulated echoes. J. Magn. Reson. 72, 502-508 (1987).
76. Frahm J, Bruhn H, Gyngell ML, Merboldt KD, Hanicke W, Sauter R. Localized high-resolution proton spectroscopy using stimulated echoes: initial applications to human brain in vivo. Magn. Reson. Med. 9, 79-93 (1989). (Pubitemid 19044561)
77. Ordidge RJ. Random noise selective excitation pulses. Magn. Reson. Med. 5, 93-98 (1987). (Pubitemid 17109500)
78. Tran TK, Vigneron DB, Sailasuta N et al. Very selective suppression pulses for clinical MRSI studies of brain and prostate cancer. Magn. Reson. Med. 43, 23-33 (2000). (Pubitemid 30027109)
79. Brown TR, Kincaid BM, Ugurbil K. NMR chemical shift imaging in three dimensions. Proc. Natl Acad. Sci. USA 79, 3523-3526 (1982). (Pubitemid 12011397)
80. Maudsley AA, Hilal SK, Perman WH, Simon HE. Spatially resolved high-resolution spectroscopy by four-dimensional NMR. J. Magn. Reson. 51, 147-152 (1983).
81. Haase A, Frahm J, Hanicke W, Matthaei D. 1H NMR chemical shift selective (CHESS) imaging. Phys. Med. Biol. 30, 341-344 (1985). (Pubitemid 15110036)
82. Frahm J, Michaelis T, Merboldt KD, Hanicke W, Gyngell ML, Bruhn H. On the N-acetyl methyl resonance in localized 1H NMR spectra of human brain in vivo. NMR Biomed. 4, 201-204 (1991).
83. Pouwels PJ, Frahm J. Differential distribution of NAA and NAAG in human brain as determined by quantitative localized proton MRS. NMR Biomed. 10, 73-78 (1997). (Pubitemid 27332604)
84. Edden RA, Pomper MG, Barker PB. In vivo differentiation of N-acetyl aspartyl glutamate from N-acetyl aspartate at 3 Tesla. Magn. Reson. Med. 57, 977-982 (2007). (Pubitemid 46911282)
85. Birken DL, Oldendorf WH. N-acetyl-l-aspartic acid: a literature review of a compound prominent in 1H-NMR spectroscopic studies of the brain. Neurosci. Biobehav. Rev. 13, 23-31 (1989). (Pubitemid 19215166)
86. Tsai G, Coyle JT, Tsai G, Coyle JT. N-acetylaspartate in neuropsychiatric disorders. Prog. Neurobiol. 46, 531-540 (1995).
87. Moffett JR, Ross B, Arun P, Hadhavarao CN, Namboodiri AM. N-acetylaspartate in the CNS: from neurodiagnostics to neurobiology. Prog. Neurobiol. 81, 89-131 (2007). (Pubitemid 46282272)
88. Bruhn H, Frahm J, Gyngell ML, Merboldt KD, Hanicke W, Sauter R. Cerebral metabolism in man after acute stroke: observations using localized proton NMR spectroscopy. Magn. Reson. Med. 9, 126-131 (1989). (Pubitemid 19044566)
89. Gideon O, Hendrickson O, Sperling B et al. Early time-course of N-acetylaspartate, creatine and phophocreatine, and compounds containing choline in the brain after acute stroke. Stroke 23, 1566-1572 (1992).
90. Li C, Ling X, Liu S et al. Early detection of secondary damage in ipsilateral thalamus after acute infarction at unilateral corona radiata by diffusion tensor imaging and magnetic resonance spectroscopy. BMC Neurol. 11, 49-57 (2011).
91. Bruhn H, Frahm J, Gyngell ML et al. Noninvasive differentiation of tumors with use of localized 1H-MR spectroscopy in vivo: initial experience in patients with vertebral tumors. Radiology 172, 541-548 (1989). (Pubitemid 19184903)
92. Ozturk-Isik E, Chen AP, Crane et al. 3D sensitivity encoded ellipsoidal MR spectroscopic imaging of gliomas at 3 T. Magn. Reson. Imaging 27, 1249-1257 (2009).
93. Calvar JA, Meli FJ, Romero C et al. Characterization of brain tumors by MRS, DWI and Ki-67 labeling index. J. Neurooncol. 72, 273-280 (2005). (Pubitemid 40867413)
94. Dowling C, Bollen AW, Noworolski SM et al. Preoperative proton MR spectroscopic imaging of brain tumors: correlation with histopathologic analysis of resection specimens. Am. J. Neuroradiol. 22, 604-612 (2001). (Pubitemid 32318684)
95. Arnold DL, Mathews PM, Francis G, Antel J. Proton magnetic resonance spectroscopy of human brain in vivo in the evaluation of multiple sclerosis. Assessment of the load of disease. Magn. Reson. Med. 14, 154-159 (1990). (Pubitemid 20243873)
96. Matthews PM, De Stefano N, Narayanan S et al. Putting magnetic resonance spectroscopy studies in context: axonal damage and disability in multiple sclerosis. Semin. Neurol. 18, 327-336 (1998). (Pubitemid 28488949)
97. Narayana PA. Magnetic resonance spectroscopy in the monitoring of multiple sclerosis. J. Neuroimaging 15, 46S-57S (2005). (Pubitemid 43010531)
98. Brief EE, Vavasour IM, Laule C, Li DK, Mackay AL. Proton MRS of large multiple sclerosis lesions reveal subtle changes in metabolite T1 and area. NMR Biomed. 23, 1033-1037 (2010).
99. Tofts PS, Wray S. A critical assessment of methods of measuring metabolite concentrations by NMR-spectroscopy. NMR Biomed. 1, 1-10 (1088).
100. Frahm J, Bruhn H, Gyngell L, Merboldt KD, H'niche W, Sauter R. Localized proton NMR spectroscopy in different regions of the human brain in vivo. Relaxation times and concentration of cerebral metabolites. Magn. Reson. Med. 11, 47-63 (1989). (Pubitemid 19159400)
101. Lee J, Yamafuchi T, Abe A et al. Clinical evaluation of choline measurement by proton spectroscopy in patients with malignant tumors. Radiat. Med. 22, 148-154 (2004). (Pubitemid 38980992)
102. Su MYL. Detection of choline signal in human breast lesions with chemical-shift imaging. J. Magn. Reson. Imaging 27, 1114-1121 (2009).
103. Davie CA, Hawkins CP, Barker GJ et al. Detection of myelin breakdown products by proton magnetic resonance spectroscopy Lancet 34, 630-631 (1993). (Pubitemid 23066176)
104. Brenner RE, Munro PM, Williams SC et al. The proton NMR spectrum in acute EAE: the significance of the change in the Cho:Cr ratio. Magn. Reson. Med. 29, 737-745 (1993). (Pubitemid 23182855)
105. Chang L, Lee PL, Yiannoutsos CT et al. A multicenter in vivo protoN-MRS study of HIV-associated dementia and its relationship to age. Neuroimage 23, 1336-1347 (2004). (Pubitemid 40260357)
106. Penrice J, Cady EB, Lorek A et al. Proton magnetic resonance spectrosocpy of the brain in normal preterm and term infants, and early changes after perinatal hypoxia-ischemia. Pediatr. Res. 40, 6-14 (1996). (Pubitemid 26196592)
107. Petroff, OA, Graham GD, Blamire AM et al. Spectroscopic imaging of stroke in humans: histopathology correlates of spectral changes. Neurology 42, 1349-1354 (1992).
108. Barker PB, Gillard JH, van Zijl PC et al. Acute stroke: evaluation with serial proton MR spectroscopic imaging. Radiology 192, 723-732 (1994). (Pubitemid 24266788)
109. Yamasaki F, Kurisu K, Kajiwara Y et al. Magnetic resonance spectroscopic detection of lactate is predictive of a poor prognosis in patients with diffuse intrinsic pontine glioma. Neuro. Oncol. 13, 791-801 (2011).
110. Mathews PM, Andermann F, Silver K, Karpati G, Arnold DL. Proton MR spectrosocpic characterization of differences in regional brain metabolic abnormalities in mitochondrial encephalomyopathies. Neurology 43, 2484-2490 (1992). (Pubitemid 24004532)
111. Lewey DA, Wald LL, Star-Lack JM. Lactate detection at 3T: compensating J coupling effects with BASING. J. Magn. Reson. Imaging 9, 732-737 (1999). (Pubitemid 29211169)
112. Catani M, Cherubini A, Howard R et al. 1H-MR spectroscopy differentiates mild cognitive impairment from normal brain aging. Neuroreport 12, 2315-2317 (2001). (Pubitemid 32682179)
113. Griffin JL, Bollard M, Nicholson JK, Bhakoo K. Spectral profiles of cultured neuronal and glial cells derived from HRMAS 1H NMR spectroscopy. NMR Biomed. 15, 375-384 (2002).
114. Wolfson M, Bersudsky Y, Hertz E et al. A model of inositol compartmentation in astrocytes based upon efflux kinetics and slow inositol depletion after uptake inhibition. Neurochem. Res. 25, 977-982 (2000). (Pubitemid 30636997)
115. Glanville NT, Byers DM, Cook HW, Spence MW, Palmer FB. Differences in the metabolism of inositol and phosphoinositides by cultured cells of neuronal and glial origin. Biochim. Biophys. Acta 1004, 169-179 (1989). (Pubitemid 19193177)
116. Ross BD, Bluml S, Cowan R et al. In vivo MR spectroscopy of human dementia. Neuroimaging Clin. N. Am. 8, 809-822 (1998). (Pubitemid 28532518)
117. Auld DS, Robitaille R. Glial cells and neurotransmission: an inclusive view of synaptic function. Neuron 40, 389-400 (2003). (Pubitemid 37244103)
118. +/myoinositol cotransport in rat cortical astrocytes. Glia 12, 35-43 (1994). (Pubitemid 2145963)
119. Mescher M, Merkle H, Kirsch J, Garwood M, Gruetter R. Simultaneous in vivo spectral editing and water suppression. NMR Biomed. 11, 266-272 (1998). (Pubitemid 28465190)
120. Waddell KW, Avison MJ, Joers JM, Gore JC. A practical guide to robust detection of GABA in human brain by J-difference spectroscopy at 3 T using a standard volume coil. Magn. Reson. Imaging 25, 1032-1038 (2007). (Pubitemid 47239276)
121. Ke Y, Cohen BM, Bang JY, Yang M, Renshaw PF. Assessment of GABA concentration in human brain using two-dimensional proton magnetic resonance spectroscopy. Psychiatry Res. 100, 169-178 (2000).
122. Shen J, Shungu DC, Rothman DL. In vivo chemical shift imaging of gammaaminobutyric acid in the human brain. Magn. Reson. Med. 41, 35-42 (1999). (Pubitemid 29068033)
123. McLean MA, Busza AL, Wald LL, Simister RJ, Barker GJ, Williams SR. In vivo GABA+ measurement at 1.5T using a PRESS-localized double quantum filter. Magn. Res. Med. 48, 233-241 (2002). (Pubitemid 34809411)
124. Mullins PG, Chen H, Xu J, Caprihan A, Gasparovic C. Comparative reliability of proton spectroscopy techniques designed to improve detection of J-coupled metabolites. Magn. Reson. Med. 60, 964-969 (2008).
125. Puts NAJ, Edden RAE. In vivo magnetic resonance spectroscopy of GABA: a methodological review. Prog. Nuc. Magn. Res. Spectrosc. doi:10.1016/j.pnmrs. 2011.06.001 (2011) (Epub ahead of print).
126. Childs C, Hiltunen Y, Vldyasagar R, Kauppinen RA. Determination of regional brain temperature using proton magnetic resonance spectroscopy to assess brain-body temperature differences in healthy human subjects. Magn. Reson. Med. 57, 59-66 (2007). (Pubitemid 46067937)
127. Burt CT, Glonek T, Baraay M, Analysis of phosphate metabolites in intracellular pH and the state of adenosine triphosphate in the intact muscle by phosphorus nuclear magnetic resonance. J. Biol. Chem. 251, 2584-2591 (1976).
128. Brown TR, Ugurbil K, Shulman RG. 31P nuclear magnetic resonance measurements of ATPase kinetics in aerobic Escherichia coli cells. Proc. Natl Acad. Sci. USA 74, 5551-5553 (1977).
129. Ross BD, Radda GK, RockerG, Esiri M, Falconer-Smith J. Examination of a case of suspected McArdle's syndrome by 31P nuclear magnetic resonance. N. Engl. J. Med. 304, 1338-1342 (1981). (Pubitemid 11113692)
130. Ackerman JJ, Grove TH, Wong GG, Gadian DG, Radda GK. Mapping of metabolites in whole animals by 31P NMR using surface coils. Nature 283, 167-170 (1980). (Pubitemid 10171127)
131. Bendall MR, Gordon RE. Depth and refocusing pulses designed for multipulse NMR with surface coils. J. Mag. Res. 53, 365-385 (1983).
132. Bendall MR. Surface coils and depth resolution using the spatial variation of RF field. James TL, Margulis AR (Eds). In: Biomedical Magnetic Resonance. Radiology Research and Education Foundation. San Francisco, CA, USA (1983).
133. Wylezinska M, Cobbold JF, Fitzpatrick J et al. A comparison of single-voxel clinical in vivo hepatic 31P MR spectra acquired at 1.5 and 3.0 Tesla in health and diseased states. NMR Biomed. 24, 231-237 (2011).
134. Holloway C, ten Hove M, Clarke K, Neubauer S. MR spectroscopy in heart failure. Front. Biosci. (Schol. Ed.) 3, 331-340 (2011).
135. Bottomley PA, Foster TH, Darrow RD. Depth resolved surface coil spectroscopy (DRESS) for in vivo 1H, 31P and 13C-NMR. J. Magn. Reson. 59, 338-342 (1984).
136. Ordidge RJ, Connelly A, Lohman JAB. Image-selected in vivo spectroscopy (ISIS). A new technique for spatially selective NMR spectroscopy. J. Magn. Reson. 66, 283-294 (1986).
137. Brophy PJ, Hayer MK, Riddell FG. Measurement of intracellular potassium ion concentrations by NMR. Biochem. J. 210, 961-963 (1983). (Pubitemid 13092036)
138. Ogino T, Shulman GI, Avison MJ, Gullans SR, den Hollander JA, Shulman RG. 23Na and 39K NMR studies of ion transport in human erythrocytes. Proc. Natl Acad. Sci. USA 82, 1099-1103 (1985). (Pubitemid 15107822)
139. Thulborn KR, Davis D, Snyder J, Yonas H, Kassam A. Sodium MR imaging of acute and subacute stroke for assessment of tissue viability. Neuroimaging Clin. N. Am. 15, 639-653 (2005). (Pubitemid 41796944)
140. Wetterling F, Gallagher L, Macrae IM, Junge S, Fagan AJ. Regional and temporal variations in tissue sodium concentration during the acute stroke phase. Magn. Reson. Med. doi:10.1002/mrm.23031 (2011) (Epub ahead of print).
141. Ouwerkerk R, Bleich KB, Gillen JS, Pomper MG, Bottomley PA. Tissue sodium concentration in human brain tumors as measured with 23Na MR imaging. Radiology 227, 529-537 (2003). (Pubitemid 36514773)
142. Haneder S, Konstandin S, Morelli JN et al. Quantitative and qualitative 23Na MR imaging of the human kidneys at 3 T: before and after a water load. Radiology 260, 857-865 (2011).
143. Chang G, Wang L, Schweitzer ME, Regatte RR. 3D 23Na MRI of human skeletal muscle at 7 Tesla: initial experience. Eur. Radiol. 20, 2039-2046 (2010).
144. Jacobs MA, Stearns V, Wolff AC et al. Multiparametric magnetic resonance imaging, spectroscopy and multinuclear (''Na) imaging monitoring of preoperative chemotherapy for locally advanced breast cancer. Acad. Radiol. 17, 1477-1485 (2010).
145. Constantinides CD, Kraitchman DL, O'Brien KO, Boada FE, Gillen J, Bottomley PA. Noninvasive quantification of total sodium concentrations in acute reperfused myocardial infarction using 23Na MRI. Magn. Reson. Med. 46, 1144-1151 (2001). (Pubitemid 33104302)
146. Jerecic R, Bock M, Nielles-Vallespin, Wacker C, Bauer W, Schad LR. ECG-gated 23Na-MRI of the human heart using 3D-radial projection technique with ultra-short echo times. Magn. Reson. Mater. Phys. 16, 297-302 (2004). (Pubitemid 39006333)
147. Nagel AM, Laun FB, Weber MA, Matthies C, Semmler W, Schad LR. Sodium MRI using a density-adapted 3D radial acquisition technique. Magn. Reson. Med. 62, 1565-1573 (2009).
148. Konstandin S, Nagel AM, Heiler PM, Schad LR. Two-dimensional radial acquisition technique with density adaption in sodium MRI. Magn. Reson. Med. 65, 1090-1096 (2011).
149. Rashid SA, Adam WR, Craik DJ, Shehan BP, Wellard RM. Factors affecting 39K NMR detectability in rat tissue. Magn. Reson. Med. 17, 213-224 (1991).
150. Adam WR, Koretsky AP, Weiner MW. Measurement of tissue potassium in vivo using 39K nuclear magnetic resonance. Biophys. J. 51, 265-271 (1987). (Pubitemid 17008705)
151. Gupta RK, Gupta P. Direct observation of resolved resonances from intra and extracelluar sodium-23 ions in NMR studies of intact cells and tissues using dysprosium(III)-tripolyphosphate as paramagnetic shift reagent. J. Magn. Reson. 47, 3344-3350 (1982).
152. Pike MM, Fossel, ET, Smith TW, Springer CS. High-resolution 23Na-NMR studies of erythrocytes: use of aqueous shift reagents. Am. J. Physiol. 246, C528-C536 (1984). (Pubitemid 14119507)
153. Pike MM, Frazer JC, Dedrick DF et al. 23Na and 39K nuclear magnetic resonance studies of perfused rat hearts. Discrimination of intra- and extracellular ions using a shift reagent, Biophys. J. 48, 159-173 (1985). (Pubitemid 15028685)
154. Ruiz-Cabelloa J, Brad P. Barnetta BP, Bottomley PA, Bultea JWM. Fluorine (19F) MRS and MRI in biomedicine. NMR Biomed. 24, 114-129 (2011).
155. Price TB, Gore JC. Effect of muscle glycogen content on exercise-induced changes in muscle T2 times. J. Appl. Physiol, 84,1178-1184 (1998). (Pubitemid 28158681)
156. Tomiyasua M, Obataa T, Nonakaa H et al. Evaluating glycogen signal contamination in muscle by 13C MRS of the liver. Magn. Reson. Imaging 26, 572-576 (2008).
157. Golman K, Ardenkjaer-Larsen JH, Petersson JS, Mansson S, Leunbach I. Molecular imaging with endogenous substances. Proc. Natl Acad. Sci. USA 100, 10435-10439 (2003). (Pubitemid 37071896)
158. Ardenkjaer-Larsen JH, Fridlund B, Gram A, et al. Increase in signal-to-noise ratio >10,000 times in liquid state NMR. Proc. Natl Acad. Sci. USA 100, 10158-10163 (2003). (Pubitemid 37071849)
159. Kurhanewicz J, Bok R, Nelson SJ, Vigneron DB. Current and potential applications of clinical 13C-MR spectroscopy. J. Nucl. Med. 49, 341-344 (2008). (Pubitemid 351355216)
160. Barker PB, Bizzi A, De Stefano N, Gullapalli R, Lin DDM. Clinical MR Spectroscopy Techniques and Applications. Cambridge University Press, Cambridge, UK, 39-40 (2010).
161. Soher BJ, van Zijl PC, Duyn JH, Barker PB. Quantitative proton spectroscopic imaging of the human brain. Magn. Reson. Med. 35, 356-363 (1996). (Pubitemid 26072107)
162. Hetherington HP, Mason GF, Pan JW et al. Evaluation of cerebral fray and white matter metabolic differences by spectroscopic imaging at 4.1T. Magn. Reson. Med. 32, 565-571 (1994). (Pubitemid 24338203)
163. Stockler S, Holzbach U, Hanefeld F et al. Creatine defiecieny in the brain: a new treatable inborn error of metabolites. Pediatr. Res. 36, 409-413 (1994). (Pubitemid 24256792)
164. Barker PB, Soher BJ, Blackband SJ, Chatham JC, Mathews VP, Bryan RN. Quantitation of proton NMR spectra of the human brain using tissue water as an interanal concentration reference. NMR Biomed. 6, 89-94 (1993).
165. Soher BJ, Hurd RE, Sailasuta N, Barker PB. Quantitation of automated single-voxel proton MRS using cerebral water as an internal reference. Magn. Reson. Med. 36, 335-339 (1996). (Pubitemid 26299257)
166. Alger JR, Symko SC, Bizzi A, Posse S, Despres DJ, Armstrong MR. Absolute quantitation of short TE brain 1H-MR spectra and spectroscopic imaging data. J. Comput. Ass. Topogr. 17, 191-199 (1993). (Pubitemid 23086433)
167. Mierisova S, Ala-Korpela M. MR spectroscopy quantitation: a review of frequency domain methods. NMR Biomed. 14, 247-259 (2001). (Pubitemid 32611436)
168. Marshall I, Bruce SD, Higinbotham J et al. Choice of spectroscopic lineshape model affects metabolite peak areas and area ratios. Magn. Reson. Med. 44, 646-649 (2000).
169. Provencher SW. Automatic quantitation of localized in vivo 1H spectra with LCModel. NMR Biomed. 14, 260-264 (2001). (Pubitemid 32611437)
170. Stefan D, Di Cesare F, Andrasescu A et al. Quantitation of magnetic resonance spectroscopy signals: the jMRUI software package. Measur. Sci. Technol. 20, 104035-104044 (2009).
171. van der Veen JWC, de Beer R, Luyten PR, van Ormondt D. Accurate quantification of in vivo 31P NMR signals using the variable projection method and prior knowledge. Magn. Reson. Med. 6, 92-98 (1988). (Pubitemid 18057210)
172. Vanhamme L, van den Boogaart A, Van Huffel S. Improved method for accurate and efficient quantification of MRS data with use of prior knowledge. J. Magn. Reson. 129, 35-43 (1997). (Pubitemid 127454051)
173. Kreis R, Ernst T, Ross B. Development of the human brain: in vivo quantification of metabolite and water content with proton magnetic resonance spectroscopy. Magn. Reson. Med. 30, 424-437 (1993). (Pubitemid 23300070)
174. TkáckI, Öz G, Adriany G, Ugurbil K, Gruetter R. In vivo 1H NMR spectroscopy of the human brain at high magnetic fields: Metabolite quantification at 4T vs 7T. Magn. Reson. Med. 62, 868-879 (2009).
175. Emir UE, Auerbach EJ, Van De Moortele PF et al. Regional neurochemical profiles in the human brain measured by 1H-MRS at 7T using local B1 shimming. NMR Biomed. doi:10.1002/nbm.1727 (2011) (Epub ahead of print).